Mycamine

Active Ingredient(s): Micafungin
FDA Approved: * March 16, 2005
Pharm Company: * ASTELLAS
Category: Antifungal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Mycamine Overview

Micafungin, sold under the brand name Mycamine, is a polyene antifungal medication used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration (FDA) on March 16, 2005, and gained approval in the European Union on April 25, 2008. Contents ...

Read more Mycamine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Micafungin

Recent Mycamine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Mycamine: (2 results)

Sorted by National Drug Code

• 0469-3211 Mycamine 20 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Astellas Pharma Us, Inc.
• 0469-3250 Mycamine 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Astellas Pharma Us, Inc.

Other drugs which contain Micafungin or a similar ingredient: (1 result)

• MICAFUNGIN